|
|
| Product Name: | AT9283 | | Synonyms: | T9283;1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea (S)-2-;AT9283;AT 9283, (2S)-2-hydroxy-propanoic acid salt;(2S)-2-Hydroxypropanoic acid compd. with N-cyclopropyl-N'-[3-[6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea;RWYNKTMXFIMBFE-WNQIDUERSA-N;AT-9283 L-Lactate;AT9283 USP/EP/BP | | CAS: | 896466-76-5 | | MF: | C22H29N7O5 | | MW: | 471.52 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 896466-76-5.mol |  |
| | AT9283 Chemical Properties |
| Melting point | >164°C (dec.) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | color | Off-White |
| | AT9283 Usage And Synthesis |
| Uses | AT-9283 is a potent AuroraA/AuroraB and multi-kinase inhibitor. AT-9283 has shown to inhibit growth and survival of multiple solid tumor cell lines and is efficacious in mouse xenograft models. It is a COVID19-related research product. |
| | AT9283 Preparation Products And Raw materials |
|